About POZEN
POZEN Inc. is a progressive pharmaceutical company committed to transforming how the healthcare industry addresses unmet medical needs. By utilizing a unique in-source model and focusing on integrated therapies, POZEN has successfully developed and obtained Federal Drug Administration (FDA) approval of two self-invented products in two years. Funded by these two milestone/royalty streams, POZEN is now creating a portfolio of cost-effective, evidence-based integrated aspirin therapies designed to enable the full power of aspirin by reducing its GI damage.
Since its founding in 1996, POZEN has successfully created novel pharmacologic agents primarily for pain and pain-related conditions by combining existing drug therapies that result in superior patient outcomes. Moving forward, POZEN is poised to become a model 21st century pharmaceutical company. POZEN, headquartered in Chapel Hill North Carolina, is dedicated to producing cost-effective, evidence-based medicines; taking a fresh approach to sales, marketing and medical education; and delivering high-quality, affordable pharmaceuticals.
POZEN. Transforming medicine. Transforming lives.
News
Stock Ticker
Stock Symbol: POZN
02/03/12 4:00 p.m. ET
NASDAQ: Pozen $4.74
Change: + 0.19 (4.18%)
Volume: 145,884